Verified Nov 2026
Batteries & E-Mobility
·
Minneapolis, Minnesota
·
Since 1981
Bio-Techne is a life sciences company headquartered in Minneapolis, Minnesota, founded in 1981 and publicly traded under the ticker TECH. It develops and sells reagents, analytical instruments, and diagnostic products for research, diagnostic, and bioprocessing markets, serving academic researchers, biopharmaceutical companies, and clinical laboratories. The company employs between 1,000 and 5,000 people and reported revenue in the range of $1.2 billion. In June 2026, Merck KGaA agreed to acquire Bio-Techne, and shareholders approved the deal in September 2026.
Bio-Techne at a glance
Revenue
1.2B
Employees
1,000-5,000
Founded
1981
Headquarters
Minneapolis, Minnesota
Ownership
Publicly traded (NASDAQ: TECH)
Certifications
ISO 13485 · ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Plumbing & Hardware
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & strong
45 years in operation (founded 1981).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
Bio-Techne is a life sciences company headquartered in Minneapolis, Minnesota, founded in 1981 and publicly traded under the ticker TECH. It develops and sells reagents, analytical instruments, and diagnostic products for research, diagnostic, and bioprocessing markets, serving academic researchers, biopharmaceutical companies, and clinical laboratories. The company employs between 1,000 and 5,000 people and reported revenue in the range of $1.2 billion. In June 2026, Merck KGaA agreed to acquire Bio-Techne, and shareholders approved the deal in September 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 1981 |
Headquarters | Minneapolis, Minnesota |
Employees | 1,000-5,000 |
Revenue | 1.2B |
Ownership | Publicly traded (NASDAQ: TECH) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 · ISO 9001 |
What Bio-Techne makes
The company holds ISO 9001 and ISO 13485 certifications and lists product and assembly offerings across its life sciences portfolio.
Products and capabilities described on the company's own site include Assembly (source: bio-techne.com).
Certifications
Bio-Techne is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — bio-techne.com
ISO 9001 — bio-techne.com
Latest developments
2026-10-08 — Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development :: Bio-Techne Corporation (TECH) (bio-techne.com)
2026-09-23 — Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany :: Bio-Techne Corporation (TECH) (bio-techne.com)
2026-06-25 — Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets :: Bio-Techne Corporation (TECH) (bio-techne.com)
2026-03-25 — Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite :: Bio-Techne Corporation (TECH) (bio-techne.com)
2025-11-18 — Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio :: Bio-Techne Corporation (TECH) (bio-techne.com)
2025-10-09 — Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 :: Bio-Techne Corporation (TECH) (bio-techne.com)
Company details
Bio-Techne has around 3,100 employees across 34 locations, according to its public profile, and expanded its COMET spatial biology suite in March 2026. Bio-Techne was founded in 1981, has an estimated 1,000-5,000 employees, and is headquartered in Minneapolis, Minnesota. On the LightSource stability read it is rated "Established & strong": 45 years in operation (founded 1981). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Bio-Techne make?
Bio-Techne is a life sciences company headquartered in Minneapolis, Minnesota, founded in 1981 and publicly traded under the ticker TECH. It develops and sells reagents, analytical instruments, and diagnostic products for research, diagnostic, and bioprocessing markets, serving academic researchers, biopharmaceutical companies, and clinical laboratories. The company employs between 1,000 and 5,000 people and reported revenue in the range of $1.2 billion. In June 2026, Merck KGaA agreed to acquire Bio-Techne, and shareholders approved the deal in September 2026.
Where is Bio-Techne headquartered?
Bio-Techne is headquartered in Minneapolis, Minnesota (614 McKinley Place Northeast, Minneapolis, Minnesota, 55413).
When was Bio-Techne founded?
Bio-Techne was founded in 1981.
How big is Bio-Techne?
Bio-Techne has an estimated 1,000-5,000 employees, with revenue in the 1.2B range.
Is Bio-Techne publicly traded?
Publicly traded (NASDAQ: TECH). Public financial figures are drawn from its filings.
What certifications does Bio-Techne hold?
Bio-Techne lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.